Epidemiology of progressive supranuclear palsy

Neurological Sciences

Volumn 22, Issue 1, 2001, Pages 101-103

  Vanacore, N ^a   Bonifati, V ^a   Colosimo, C ^a   Fabbrini, G ^a   De Michele, G ^b   Marconi, R ^c   Nicholl, D ^d   Locuratolo, N ^a   Romano, S ^a   Talarico, G ^a   Stocchi, F ^a   Bonuccelli, U ^e   Lamberti, P ^f   Vieregge, P ^g   Meco, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c MISERICORDIA HOSPITAL   (Italy)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g Kinikum Lippe Lemgo   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ARTICLE; BEVERAGE; CLINICAL TRIAL; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC SCREENING; GENETICS; GUADELOUPE; HUMAN; INCIDENCE; MALE; MULTICENTER STUDY; MUTATION; OCCUPATIONAL DISEASE; ONSET AGE; PATHOPHYSIOLOGY; PREVALENCE; PROGRESSIVE SUPRANUCLEAR PALSY; RISK FACTOR; SEX DIFFERENCE;

AGE OF ONSET; BEVERAGES; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC SCREENING; GUADELOUPE; HUMANS; INCIDENCE; MALE; MUTATION; OCCUPATIONAL DISEASES; PREVALENCE; RISK FACTORS; SEX FACTORS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 18044401964     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720170065     Document Type: Article

References (10)

1. Hauw JJ, Daniel SE, Dickson D et al (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015-2019
2. Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS (1988) Risk factors for the progressive supranuclear palsy. Neurology 38:1546-1552
3. Litvan I, Agid Y, Jankovic J et al (1996) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46:922-930
4. Bower JH, Maraganore DM, Mc Donnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976-1990. Neurology 49:1284-1288
5. Caparros-Lefebvre D, Elbaz A and the Caribbean Parkinsonism Study Group (1999) Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Lancet 354:281-286
6. Golbe LI, Rubin RS, Cody RP et al (1996) Follow-up study of risk factors in progressive supranuclear palsy. Neurology 47:148-154
7. Rojo A, Pernaute RS, Fontan A et al (1999) Clinical genetics of familial progressive supranuclear palsy. Brain 122:1233-1245
8. Bennett P, Bonifati V, Bonuccelli U et al (1998) Direct genetic-evidence for involvement of tau in progressive supranuclear palsy. Neurology 51:982-985
9. Bonifati V, Joosse M, Nicholl D et al (1999) The tau gene in progressive supranuclear pasly: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases. Neurosci Lett 274:61-65
10. Fabbrini G, Vanacore N, Bonifati V, Colosimo C, Meco G for the Study Group on Atypical Parkinsonisms (1998) Presymptomatic hypertension in progressive supranuclear palsy. Arch Neurol 55:1153-1155